https://biotechmorning.com/news/moonlake-immunotherapeutics-data-transparency-concerns Biotech Morning en 2026-08-12T14:20:33.438Z What Is MoonLake Immunotherapeutics Afraid Of? https://biotechmorning.com/news/ivonescimab-china-squamous-nsclc-approval Biotech Morning en 2026-08-12T14:19:52.392Z The Two-in-One Cancer Drug China Can't Stop Approving https://biotechmorning.com/news/zydus-sentynl-mereo-alvelestat-rare-lung-disease-deal Biotech Morning en 2026-08-12T14:19:04.726Z Zydus Just Bet Big on a Lung Disease Most People Haven't Heard Of https://biotechmorning.com/news/pharma-us-manufacturing-tariff-wave Biotech Morning en 2026-08-12T14:18:19.558Z Half a Trillion Reasons Big Pharma Is Building Factories in America https://biotechmorning.com/news/definium-lsd-anxiety-second-phase-3-win Biotech Morning en 2026-08-12T14:17:37.174Z An LSD Pill Just Aced Its Second Anxiety Trial. Yes, Really. https://biotechmorning.com/news/itm-11-fda-rejection-manufacturing Biotech Morning en 2026-08-12T14:16:51.253Z The Drug That Worked Perfectly But Still Can't Reach Patients https://biotechmorning.com/news/vertex-cf-fortress-sionna-trial-failure Biotech Morning en 2026-08-12T14:16:08.443Z Vertex's $10 Billion CF Fortress Just Lost Its Last Serious Challenger https://biotechmorning.com/news/curium-lantheus-8-billion-radiopharmaceutical-deal Biotech Morning en 2026-08-12T14:15:42.091Z Radioactive Real Estate Just Got Its Biggest Buyer Ever https://biotechmorning.com/news/trump-executive-order-childhood-vaccine-schedule-cut Biotech Morning en 2026-08-12T14:14:53.524Z The White House Just Rewrote Your Kid's Shot Card https://biotechmorning.com/news/jazz-actio-biosciences-kcnt1-epilepsy-deal Biotech Morning en 2026-08-12T14:14:09.900Z Jazz Just Bet $1.3 Billion on a Disease Most Doctors Have Never Heard Of https://biotechmorning.com/news/fda-bespoke-gene-therapy-framework-3 Biotech Morning en 2026-08-12T14:13:21.877Z The FDA Just Made It Possible to Build a Drug for One Person